Home Retraction of: Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia
Article Open Access

Retraction of: Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia

  • Bertrand Fougère , Bruno Vellas , Gabor Abellan van Kan and Matteo Cesari
Published/Copyright: September 11, 2020
Become an author with De Gruyter Brill

The lead author and the publisher would like to inform that the article “Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia” (https://doi.org/10.1515/tnsci-2015-0009) has been retracted as per their request.

The article bears the hallmarks of plagiarism, using the unreferenced quotes from, among others, the following papers:

  1. Ali S, Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options – a mini-review. Gerontology. 2014;60(4):294–305.

  2. Bhasin S, He EJ, Kawakubo M, Schroeder ET, Yarasheski K, Opiteck G, et al. N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone. J Clin Endocrinol Metab. 2009;94(11):4224–33. doi: 10.1210/jc.2009-1434.

  3. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med. 2008 Dec;29(6):407–14.

  4. Cesari M, Fielding RA, Pahor M, Goodpaster B, Hellerstein M, van Kan GA, et al. International Working Group on Sarcopenia. Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle. 2012;3(3):181–90. doi: 10.1007/s13539-012-0078-2.

  5. Cooper C, Dere W, Evans W, Kanis JA, Rizzoli R, Sayer AA, et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporosis Int. 2012;23:1839–48. doi: 10.1007/s00198-012-1913-1.

  6. Cruz-Jentoft AJ, Michel JP, Cruz-Jentoft AJ, Michel J-P. Sarcopenia: a useful paradigm for physical frailty. Eur Geriatr Med. 2013;4(2):102–5.

  7. Drey M, Sieber CC, Bauer JM, Uter W, Dahinden P, Fariello RG, et al. C-terminal agrin fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction. Exp Gerontol. 2013;48(1):76–80. doi: 10.1016/j.exger.2012.05.021.

  8. Feng J, He W, Song Y, Wang Y, Simpson R, Zhang X, et al. Platelet-derived growth factor receptor beta: a novel urinary biomarker for recurrence of non-muscle-invasive bladder cancer. PLoS One. 2014;9(5):e96671. doi: 10.1371/journal.pone.0096671.

  9. Fulle S, Protasi F, Di Tano G, Pietrangelo T, Beltramin A, Boncompagni S, et al. The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp Gerontol. 2004;39(1):17–24. doi: 10.1016/j.exger.2003.09.012.

  10. Patel SS, Molnar MZ, Tayek JA, Ix JH, Noori N, Benner D, et al. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle. 2013;4(1):19–29. doi: 10.1007/s13539-012-0079-1.

  11. Scharf G, Heineke J. Finding good biomarkers for sarcopenia. J Cachexia Sarcopenia Muscle. 2012 Sep;3(3):145–8.

Received: 2020-08-26
Accepted: 2020-08-27
Published Online: 2020-09-11

© 2020 Bertrand Fougère et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Changing the tone of clinical study design in the cannabis industry
  3. Integrated Chinese and western medicine for acute guillain-barré syndrome treatment
  4. Hydrochloride fasudil attenuates brain injury in ICH rats
  5. Protective role of maize purple plant pigment against oxidativestress in fluorosis rat brain
  6. A novel low-cost electrode for recording the local field potential of freely moving rat’s brain
  7. Neuroprotective mechanisms of erythropoietin in a rat stroke model
  8. Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
  9. Dysbiosis characteristics of gut microbiota in cerebral infarction patients
  10. miR-142-3p suppresses apoptosis in spinal cord-injured rats
  11. Decreased MiR-30a promotes TGF-β1-mediated arachnoid fibrosis in post-hemorrhagic hydrocephalus
  12. Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer’s disease
  13. EGCG modulates PKD1 and ferroptosis to promote recovery in ST rats
  14. Efficacy of Novavit in ameliorating the neurotoxicity of propionic acid
  15. High-fat diet-induced obesity and impairment of brain neurotransmitter pool
  16. Erratum to “Changing the tone of clinical study design in the cannabis industry”
  17. Development of a trunk motor paradigm for use in neuroimaging
  18. Notoginsenoside R1 attenuates sevoflurane-induced neurotoxicity
  19. Saikosaponin A attenuates neural injury caused by ischemia/reperfusion
  20. Safety profile of the transcription factor EB (TFEB)-based gene therapy through intracranial injection in mice
  21. Partial enzyme digestion facilitates regeneration of crushed nerve in rat
  22. Correlation between calcium, water contents and ultrasonographic appearance of atherosclerotic lesions of carotid artery lesions
  23. Diabetes does not affect motor recovery after intracerebral hemorrhage
  24. IRF8 is crucial for the nicotine withdrawal-induced hyperalgesia in mice
  25. Prediction of muscle loss after stroke by analysis of corticospinal tract
  26. Interleukin-27 levels in patients with myasthenia gravis
  27. Artesunate attenuates traumatic brain injury-induced impairments in rats
  28. BDMC protects AD in vitro via AMPK and SIRT1
  29. Injury of the optic radiation in patients with mild TBI: A DTT study
  30. Time-restricted feeding alters isoflurane-induced memory deficits
  31. Video-based education improves the image quality of diagnostic percutaneous cerebral angiography among elderly patients
  32. The effect of rTMS in the management of pain associated with CRPS
  33. EGCG treats ICH via up-regulating miR-137-3p and inhibiting Parthanatos
  34. Modified hemispherectomy for infantile hemiparesis and epilepsy
  35. Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling
  36. Epitranscriptome of the ventral tegmental area in a deep brain-stimulated chronic unpredictable mild stress mouse model
  37. Role of prefrontal cortex during Sudoku task: fNIRS study
  38. Tongxinluo promotes axonal plasticity and functional recovery after stroke
  39. Eriodictyol corrects functional recovery and myelin loss in SCI rats
  40. Letter to the Editor
  41. Ataxic hemiparesis after corona radiata infarct: Diffusion tensor imaging correlation of corticoponto-cerebellar tract injury
  42. Compression of the lateral antebrachial cutaneous nerve by a traumatic arteriovenous fistula
  43. Rapid Communication
  44. Anticholinergic drugs and oral health-related quality of life in patients with schizophrenia: a pilot study
  45. Deviant cortical sulcation related to schizophrenia and cognitive deficits in the second trimester
  46. Case Report
  47. A case of primary central nervous system lymphoma mimic neuromyelitis optica
  48. A Moving Residual Limb: Botulinum Toxin to the Rescue
  49. Clinical and imaging features of reversible splenial lesion syndrome with language disorder
  50. Impaired consciousness due to injury of the ascending reticular activating system in a patient with bilateral pontine infarction: A case report
  51. Commentary
  52. A comment on Morey et al. (2020)
  53. Review Articles
  54. Advances in transcription factors related to neuroglial cell reprogramming
  55. The “authentic subjective experience” of memory in Alzheimer’s disease
  56. Chronic neurological diseases and COVID-19: Associations and considerations
  57. Special Issue "Neuroinflammation: from basic to clinical perspectives"
  58. Ormosanine improves neuronal functions in spinal cord-injured rats by blocking peroxynitrite/calpain activity
  59. Retraction
  60. Retraction of: Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/tnsci-2020-0142/html
Scroll to top button